389 results on '"Modigliani R"'
Search Results
2. Use of anti-tumour necrosis factor agents in inflammatory bowel disease: European guidelines for 2001–2003
3. Hydrostatic balloon dilatation of Crohnʼs strictures
4. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study
5. An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
6. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method
7. Idiopathic giant oesophageal ulcer in an immunocompetent patient. The efficacy of thalidomide treatment
8. Treatment of severe Crohn's disease with anti-CD4 monoclonal antibody
9. Reply: Analysis of biological variables in Crohn's disease
10. Methotrexate for the treatment of refractory Crohn's disease
11. Distribution of Crohn's disease susceptibility haplotypes in European families
12. Mutational analysis and phenotype-genotype correlation of the NOD2 gene in Crohn disease
13. Effect of ethanol ingestion on postprandial gastric emptying and secretion, biliopancreatic secretions, and duodenal absorption in man
14. Reproducibility of colonoscopic findings in Crohn's disease: A prospective multicenter study of interobserver variation
15. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia: A double-blind placebo-controlled evaluation of cisapride
16. European trial of cyclosporine in chronic active Crohn's disease: A 12-month study
17. Validation of the use of a tube with a proximal occlusive balloon for measurement of intestinal absorption in man
18. Reply
19. Clustering of Crohn's disease within affected sibships
20. CARD4/NOD1 is not involved in inflammatory bowel disease
21. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.
22. CARD4/NOD1 in inflammatory bowel disease.
23. Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease
24. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
25. A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease
26. [Celiac disease and collagenous colitis. A fortuitous association]
27. Analysis of biological variables in Crohn's disease - Reply
28. Identifying Patients With a High-risk of Relapse in Quiescent Crohns-disease
29. Methotrexate in Crohn?s disease: long-term efficacy and toxicity
30. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method
31. Refractory sprue maybe the missing link between celiac disease and enteropathy associated T-cell lymphoma. Clinical, pathological, phenotypic and molecular evidence in a national cooperative study
32. Dose raising of azathioprine beyond 2.5 MG/KG/day in Crohn's disease patients who fail to improve with a standard dose
33. Intravenous cyclosporine for perianal Crohn's disease (CD)
34. Intravenous cyclosporine for refractory attacks of Crohn's disease (CD): Long-term follow-up of patients
35. Refractory spure: Histological and phenotypical features and outcome
36. 6-mercaptopurine and azathioprine for maintenance of remission in ulcerative colitis
37. Clinical characteristics of Crohn's disease in 72 families
38. Reply
39. Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives
40. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
41. Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD
42. Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
43. Comparison of budesonide and 5‐aminosalicylic acid enemas in active distal ulcerative colitis
44. Mesalamine(M) in Crohn's disease (CD) patients with prednisolone-induced remission: Effect on steroid weaning and remission maintenance in the year after weaning: A placebo-controlled, multicentre double-blind trial
45. A Randomized, Double-Blind, Placebo-Controlled Trial of Olsalazine for Active Crohnʼs Disease
46. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
47. Intestinal Microsporidiosis in Human Immunodeficiency Virus-Infected Patients with Chronic Unexplained Diarrhea: Prevalence and Clinical and Biologic Features
48. Les maladies inflammatoires chroniques de l'intestin
49. Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
50. Effect of intrajejunal elemental diet perfusion on jejunal secretion of immunoglobulins, albumin, and hyaluronan in man.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.